scholarly article | Q13442814 |
P50 | author | Orla Hardiman | Q30423350 |
Katy Tobin | Q40015163 | ||
James Rooney | Q58400289 | ||
Susan Byrne | Q61827445 | ||
Mark Heverin | Q89957359 | ||
P2093 | author name string | Alison Dick | |
Colette Donaghy | |||
P2860 | cites work | Survival analysis of irish amyotrophic lateral sclerosis patients diagnosed from 1995-2010. | Q34375695 |
Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000. | Q35476043 | ||
The effect of non-invasive positive pressure ventilation (NIPPV) on cognitive function in amyotrophic lateral sclerosis (ALS): a prospective study | Q35572459 | ||
Prognostic factors in ALS: A critical review | Q36447824 | ||
The natural history of motor neuron disease: assessing the impact of specialist care | Q38014082 | ||
The epidemiology of motor neuron disease in Northern Ireland using capture-recapture methodology | Q39863626 | ||
EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives | Q46832663 | ||
Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial | Q47652452 | ||
Cluster RCT of case management on patients' quality of life and caregiver strain in ALS. | Q48127223 | ||
Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. | Q51014067 | ||
Evidence of an environmental effect on survival in ALS. | Q51721412 | ||
Multidisciplinary ALS care improves quality of life in patients with ALS. | Q51924828 | ||
Amyotrophic lateral sclerosis | Q55877676 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | amyotrophic lateral sclerosis | Q206901 |
P304 | page(s) | 496-501 | |
P577 | publication date | 2014-12-30 | |
P1433 | published in | Journal of Neurology, Neurosurgery and Psychiatry | Q1599804 |
P1476 | title | A multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern Ireland | |
P478 | volume | 86 |
Q38557374 | "Anything that makes life's journey better." Exploring the use of digital technology by people living with motor neurone disease. |
Q38617893 | A Qualitative Study of Multidisciplinary ALS Clinic Use in the United States |
Q37471676 | A clinical tool for predicting survival in ALS. |
Q64894086 | A multidisciplinary clinic approach to improve physician-related diagnostic delay for patients with axial spondyloarthritis: a retrospective study. |
Q47274912 | A spatial analysis of amyotrophic lateral sclerosis (ALS) cases in the United States and their proximity to multidisciplinary ALS clinics, 2013. |
Q92339532 | Adjusted cost analysis of video televisits for the care of people with amyotrophic lateral sclerosis |
Q56531746 | Amyotrophic lateral sclerosis |
Q56531747 | Amyotrophic lateral sclerosis |
Q38715468 | Amyotrophic lateral sclerosis and frontotemporal dementia: distinct and overlapping changes in eating behaviour and metabolism |
Q33734415 | Amyotrophic lateral sclerosis: improving care with a multidisciplinary approach |
Q47590248 | Apathy is associated with poor prognosis in amyotrophic lateral sclerosis |
Q64228443 | Clinical Measures of Bulbar Dysfunction in ALS |
Q40719786 | Cognition and eating behavior in amyotrophic lateral sclerosis: effect on survival |
Q91660078 | Communicating psychosocial well-being in motor neurone disease to staff: results from a World Café approach |
Q40380484 | Compliance with recommendations made in a multidisciplinary ALS clinic |
Q39386238 | Developing multidisciplinary clinics for neuromuscular care and research. |
Q39289468 | Development of patient decision support tools for motor neuron disease using stakeholder consultation: a study protocol |
Q30691863 | Discriminant ability of the Eating Assessment Tool-10 to detect aspiration in individuals with amyotrophic lateral sclerosis. |
Q92537437 | Editorial: Biomarkers and Clinical Indicators in Motor Neuron Disease |
Q47742878 | End-of-life Characteristics and Palliative Care Provision for Patients With Motor Neuron Disease |
Q58583906 | Epidemiology of ALS in Korea using nationwide big data |
Q49691472 | Experience with telemedicine in a multi-disciplinary ALS clinic |
Q39252157 | Factors predicting survival in ALS: a multicenter Italian study |
Q37728216 | From first symptoms to diagnosis of amyotrophic lateral sclerosis: perspectives of an Irish informal caregiver cohort-a thematic analysis |
Q64274786 | High-frequency motor rehabilitation in amyotrophic lateral sclerosis: a randomized clinical trial |
Q46604820 | Improving symptom management for people with amyotrophic lateral sclerosis |
Q50545364 | Incorporation of telehealth into a multidisciplinary ALS Clinic: feasibility and acceptability. |
Q33786829 | Inherited Paediatric Motor Neuron Disorders: Beyond Spinal Muscular Atrophy |
Q58787868 | Maximizing the Survival of Amyotrophic Lateral Sclerosis Patients: Current Perspectives |
Q39036805 | Motor neuron disease: biomarker development for an expanding cerebral syndrome |
Q38597450 | Motor neuron disease: current management and future prospects |
Q64960348 | Palliative care for patients with motor neurone disease: current challenges. |
Q61812640 | Palliative care in motor neurone disease: where are we now? |
Q35877457 | Patient journey to a specialist amyotrophic lateral sclerosis multidisciplinary clinic: an exploratory study |
Q57488027 | Patient perspectives on transitioning to amyotrophic lateral sclerosis multidisciplinary clinics |
Q49818063 | Patient-centered decision making in amyotrophic lateral sclerosis: where are we? |
Q37164599 | Patient-reported problematic symptoms in an ALS treatment trial. |
Q93089769 | Provincial Differences in the Diagnosis and Care of Amyotrophic Lateral Sclerosis |
Q26749521 | Recent advances in amyotrophic lateral sclerosis |
Q55134199 | Referral bias in ALS epidemiological studies. |
Q93147168 | Retrospective longitudinal study of ALS in Cyprus: Clinical characteristics, management and survival |
Q48101521 | Riluzole and other prognostic factors in ALS: a population-based registry study in Italy |
Q34537070 | Supportive and symptomatic management of amyotrophic lateral sclerosis |
Q39795426 | Survival analysis of geospatial factors in the Irish ALS cohort |
Q92236845 | Survival benefit of multidisciplinary care in amyotrophic lateral sclerosis in Spain: association with noninvasive mechanical ventilation |
Q33568729 | Survival prediction in Amyotrophic lateral sclerosis based on MRI measures and clinical characteristics |
Q36293991 | The Awaji criteria increases the diagnostic sensitivity of the revised El Escorial criteria for amyotrophic lateral sclerosis diagnosis in a Chinese population |
Q57798758 | The Multiple Sclerosis Care Unit |
Q39218891 | The benefit of evolving multidisciplinary care in ALS: a diagnostic cohort survival comparison |
Q47370892 | The development of the UK National Institute of Health and Care Excellence evidence-based clinical guidelines on motor neurone disease |
Q50347043 | The evaluation of bulbar dysfunction in amyotrophic lateral sclerosis: survey of clinical practice patterns in the United States |
Q33825530 | The path to specialist multidisciplinary care in amyotrophic lateral sclerosis: A population- based study of consultations, interventions and costs |
Q35973665 | Using technology to improve access to specialist care in amyotrophic lateral sclerosis: A systematic review |
Q89618542 | What is rehabilitation? An empirical investigation leading to an evidence-based description |
Search more.